ATRA- Atara Biotherapeutics, Inc.

Name: Atara Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Panacea Innovation Ltd	1.32M	$11.05M	-
10%	Adiumentum Capital Fund I LP	377.2K	$3.15M	-
CEO	Nguyen Anhco	143.1K	$1.19M	-
?	Touchon Pascal	78.0K	$650.1K	-
Other	Grant-Huerta Yanina	52.0K	$434.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 16, 2023	Touchon Pascal82	President And CEO	Sell	20,409	$0.39	$7,939.10	-3.0%	+60.3%	-0.1%
Nov 16, 2023	Nguyen Anhco67	EVP, Chief Sci. &Tech Officer	Sell	8,856	$0.39	$3,444.98	-3.1%	+60.3%	-0.1%
Nov 16, 2023	Murugan Amar80	EVP, Chief Legal Officer	Sell	8,307	$0.39	$3,231.42	-3.1%	+60.3%	-0.1%
Nov 16, 2023	Joshi Manher	EVP, Chief Medical Officer	Sell	12,287	$0.39	$4,779.64	-6.7%	+60.3%	-0.1%
Nov 16, 2023	Hyllengren Eric J66	SVP, CFO	Sell	11,958	$0.39	$4,651.66	-5.5%	+60.3%	-0.1%
Nov 16, 2023	Henrich Jill62	EVP, Global Head Ra &Quality	Sell	3,267	$0.39	$1,270.86	-3.0%	+60.3%	-0.1%
Nov 14, 2023	Gallagher Carol Giltner	-	Buy	270,000	$0.25	$68,214.48	+48.4%	+140.7%	+64.0%
Nov 10, 2023	Dobmeier Eric	-	Buy	446,825	$0.23	$101,339.91	+383.5%	+259.4%	+96.9%
Nov 10, 2023	Heiden William K82	-	Buy	100,000	$0.25	$25,330.00	+91.7%	+259.4%	+96.9%
Aug 16, 2023	Henrich Jill62	EVP, Global Head Ra &Quality	Sell	3,346	$1.65	$5,531.50	-1.5%	-79.4%	-83.8%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC